Use the calculator above or our full calculator with syringe visualization
the initial level
cadence is program-driven, not trial-derived
Better insulin function, reduced glucagon at inappropriate times, and weight loss all contribute
Patient selection considerations include: Topical delivery : Suitable for maintenance, prevention, and mild aging concerns Injectable delivery : Appropriate for significant skin damage, deep wrinkles, and hair loss Combination protocols : Optimal for comprehensive regenerative programs Troche Delivery for Sustained Systemic Effects Troches (dissolvable lozenges placed between the cheek and gum) represent another delivery option for GHK-Cu
Participants received either tirzepatide at 5 mg, 10 mg, or 15 mg, or placebo, injected once weekly for 72 weeks